The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.

On March 17, 2025, a bipartisan group of senators introduced two bills intended to decrease the cost of prescription drugs. The sponsors include ...

The world’s largest multidisciplinary scientific society honored Brown faculty members from molecular biophysics and ...

Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria ...

Joshua Rabinowitz will direct Princeton’s role in the Weill Cancer Hub East, a collaboration with The Rockefeller University, ...

Four University of Iowa faculty members have been named 2024 fellows of the American Association for the Advancement of ...

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...

Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

Nitisinone was shown to last longer than ivermectin in the human bloodstream, and was able to kill not only mosquitoes of all ...

Makary, a prominent voice on U.S. health care practices throughout his career, spent 22 years at Hopkins Medicine ...

Fresenius said the U.S. Food and Drug Administration has approved a biologics license application for its operating company's bone-disease drugs. The approval concerns Fresenius Kabi's Conexxence and ...

In recent years, artificial intelligence (AI) has revolutionized many fields by providing advanced tools for data analysis ...